我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Impact of Glasgow Prognostic Score on Advanced Cancer Patients in Palliative Care Settings: A Short Narrative Review

Tomofumi Miura and Yoshihisa Matsumoto

Advanced cancer patients gradually experience deterioration of their physical condition and symptoms. Prognostic information is quite important for patients, their caregivers and medical staff. The Glasgow Prognostic Score (GPS)/modified GPS (mGPS) is one of the objective prognostic indicators. This study aimed to review the prevalence of GPS/mGPS and its impact on the prognostic value, physical function, quality of life and symptoms, and cancer cachexia among cancer patients who had received supportive care without plan of any anti-tumor therapy. Six studies were identified. The increase in GPS/mGPS score was correlated with poor prognosis, poor performance status and weight loss in patients without anti-tumor therapy. However, no evidence about the correlation between GPS/mGPS and activities of daily living, quality of life and symptoms existed. More detailed classification of GPS/mGPS will be needed to adequately reflect the general conditions of advanced cancer patients who have received supportive care without plan of any anti-tumor therapy.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。